CN102772685A - Traditional Chinese medicinal preparation for treating aplastic anemia - Google Patents
Traditional Chinese medicinal preparation for treating aplastic anemia Download PDFInfo
- Publication number
- CN102772685A CN102772685A CN2012102437930A CN201210243793A CN102772685A CN 102772685 A CN102772685 A CN 102772685A CN 2012102437930 A CN2012102437930 A CN 2012102437930A CN 201210243793 A CN201210243793 A CN 201210243793A CN 102772685 A CN102772685 A CN 102772685A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- aplastic anemia
- grams
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicinal preparation for treating aplastic anemia, which is mainly used for solving the problems that the existing treatment mode for treating aplastic anemia has a bad curative effect and high treatment cost. The traditional Chinese medicinal preparation is characterized by comprising the following ingredients in parts by weight: 10-30 parts of radix rehmanniae, 10-30 parts of cortex moutan, 10-25 parts of liquorice, 10-30 parts of rhizoma imperatae, 10-30 parts of herba cirsii, 10-30 parts of cornu bubali, 10-30 parts of pseudo-ginseng, 10-30 parts of angelica, 10-30 parts of codonopsis pilosula, 10-30 parts of hairyvein agrimonia, 10-30 parts of safflower and 10-30 parts of radix isatidis. The traditional Chinese medicinal preparation for treating aplastic anemia is low in cost, good in curative effect, and not easy to relapse.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, particularly a kind of Chinese medicine preparation of treating aplastic anemia.
Background technology
Aplastic anemia is called for short aplastic anemia, be one group because the marrow hemopoietic stem cells due to chemistry, physics, biological factor and the unknown cause and (or) hematopoieticmicroenviron-ment damages the one group of syndrome that causes marrow hematopoiesis function failure.Clinical manifestation is that pancytopenia reaches the anemia that causes therefrom, hemorrhage and infection.Aplastic anemia is generally divided acute aplastic anemia and chronic aplastic anemia.The main corresponding symptoms that occurs because of pancytopenia like leukopenia patient's easy infection then, occurs generating heat etc.; Erythrocytopenia and common cardiopalmus, weak, dizziness etc.; Thrombocytopenia is then seen hemorrhage situation.General anti-anemic drug commonly used is failed to respond to any medical treatment.And medical expense is high, easy relapse.
Summary of the invention
The invention reside in the mode that overcomes the existing treatment of employing that exists in the background technology and treat the high problem of aplastic anemia therapeutic effect difference expense; And a kind of Chinese medicine preparation of treating aplastic anemia is provided; This Chinese medicine preparation is with low cost, and good effect is difficult for recurrence.
The present invention solves its problem and can reach through following technical scheme: the Chinese medicine preparation of this treatment aplastic anemia, the weight portion of each component and each component is: Radix Rehmanniae 10-30 part, Cortex Moutan 10-30 part, Radix Glycyrrhizae 10-25 part, Rhizoma Imperatae 10-30 part, Herba Cirsii 10-30 part, Cornu Bubali 10-30 part, Radix Notoginseng 10-30 part, Radix Angelicae Sinensis 10-30 part, Radix Codonopsis 10-30 part, Herba Agrimoniae 10-30 part, Flos Carthami 10-30 part, Radix Isatidis 10-30 part.
The Chinese medicine preparation of treatment aplastic anemia of the present invention can be boiled into decoction by conventional pharmaceutical methods decocting and take.One twice-daily is taken sooner or later, each 200 grams.
Clinical treatment 200 routine patients with anaphylactoid purpura have 172 examples to cure, and cure rate is 86%.
Aplastic anemia is a kind of serious BLOOD DISEASE that the hemopoietic function of bone marrow obstacle causes.Aplastic anemia belongs to disease categories such as Chinese medicine " asthenia ", " marrow labor ", " blood disorder ".Chinese medicine thinks that the primary disease innate deficiency is lacked of proper care after one's birth, and body constitution is weak, or all sick mistakes control, and sick the mistake for a long time supported or the internal injury of being overworked for a very long period, and body and the spirit is crossed consumption, and gradually to the vigour loss, essence and blood is empty few, and internal organs hypofunction is due to the insufficiency of generating and transforming QI and blood.Need to adopt heat clearing away, removing heat from blood, hemostasis, hemopoietic, treatment by Chinese herbs.The Radix Rehmanniae of the Chinese medicine preparation of this treatment aplastic anemia, Cortex Moutan have the effect of removing heat from blood; Radix Glycyrrhizae can be detoxified; Rhizoma Imperatae hemostasis diuresis; Herba Cirsii, Herba Agrimoniae are used for hemostasis; The Cornu Bubali heat clearing and blood cooling; Radix Notoginseng, Flos Carthami are used to invigorate blood circulation, stop blooding; Radix Angelicae Sinensis is used to enrich blood; Radix Codonopsis is used for invigorating the spleen and replenishing QI; The Radix Isatidis heat-clearing and toxic substances removing.
The Chinese medicine preparation of this treatment aplastic anemia is with low cost, good effect, and instant effect does not recur, and no side effects is applicable to all kinds of patients.Curative effect is firm, has no adverse reaction, and the treatment total effective rate is about 86%.
The specific embodiment:
Below in conjunction with specific embodiment the present invention is further described:
Embodiment 1
The Radix Rehmanniae 10 gram, Cortex Moutan 10 grams, Radix Glycyrrhizae 10 grams, Rhizoma Imperatae 10 grams, Herba Cirsii 10 grams, Cornu Bubali 10 grams, Radix Notoginseng 10 grams, Radix Angelicae Sinensis 10 grams, Radix Codonopsis 10 grams, Herba Agrimoniae 10 grams, Flos Carthami 10 grams, Radix Isatidis 10 grams are added decocting to be boiled into decoction and to take.
Embodiment 2
The Radix Rehmanniae 30 gram, Cortex Moutan 30 grams, Radix Glycyrrhizae 25 grams, Rhizoma Imperatae 30 grams, Herba Cirsii 30 grams, Cornu Bubali 30 grams, Radix Notoginseng 30 grams, Radix Angelicae Sinensis 30 grams, Radix Codonopsis 30 grams, Herba Agrimoniae 30 grams, Flos Carthami 30 grams, Radix Isatidis 30 grams are added decocting to be boiled into decoction and to take.
Embodiment 3
The Radix Rehmanniae 15 gram, Cortex Moutan 15 grams, Radix Glycyrrhizae 13 grams, Rhizoma Imperatae 15 grams, Herba Cirsii 15 grams, Cornu Bubali 15 grams, Radix Notoginseng 15 grams, Radix Angelicae Sinensis 15 grams, Radix Codonopsis 15 grams, Herba Agrimoniae 15 grams, Flos Carthami 15 grams, Radix Isatidis 15 grams are added decocting to be boiled into decoction and to take.
Embodiment 4
The Radix Rehmanniae 18 gram, Cortex Moutan 18 grams, Radix Glycyrrhizae 16 grams, Rhizoma Imperatae 18 grams, Herba Cirsii 19 grams, Cornu Bubali 19 grams, Radix Notoginseng 19 grams, Radix Angelicae Sinensis 19 grams, Radix Codonopsis 19 grams, Herba Agrimoniae 19 grams, Flos Carthami 19 grams, Radix Isatidis 19 grams are added decocting to be boiled into decoction and to take.
Case 1: patient: the Wang, man 40 years old, this decoction treatment 1 month is taken by the Qiqihaer City, Heilongjiang Province, and transference cure does not have recurrence.
Case 2: patient: Liu so-and-so, woman 8 years old, this decoction was taken 2 months in the Daqing, Heilongjiang Province, disease does not more have recurrence.
Case 3: patient: Lee, man 9 years old, this decoction was taken 3 months by the Harbin City, Heilongjiang Province city, and disease does not more have recurrence.
Claims (2)
1. Chinese medicine preparation of treating aplastic anemia, it is characterized in that: the component of this Chinese medicine preparation and the weight portion of each component are: Radix Rehmanniae 10-30 part, Cortex Moutan 10-30 part, Radix Glycyrrhizae 10-25 part, Rhizoma Imperatae 10-30 part, Herba Cirsii 10-30 part, Cornu Bubali 10-30 part, Radix Notoginseng 10-30 part, Radix Angelicae Sinensis 10-30 part, Radix Codonopsis 10-30 part, Herba Agrimoniae 10-30 part, Flos Carthami 10-30 part, Radix Isatidis 10-30 part.
2. the Chinese medicine preparation of treatment aplastic anemia according to claim 1 is characterized in that: described medicament is to be processed by following materials of weight proportions: 15 parts in the Radix Rehmanniae, 15 parts of Cortex Moutans, 13 parts in Radix Glycyrrhizae, 15 parts of Rhizoma Imperataes, 15 parts of Herba Cirsiis, 15 parts of Cornu Bubalis, 15 parts of Radix Notoginseng, 15 parts of Radix Angelicae Sinensis, 15 parts of Radix Codonopsis, 15 parts of Herba Agrimoniaes, 15 parts on Flos Carthami, 15 parts of Radix Isatidis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210243793.0A CN102772685B (en) | 2012-07-16 | 2012-07-16 | Traditional Chinese medicinal preparation for treating aplastic anemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210243793.0A CN102772685B (en) | 2012-07-16 | 2012-07-16 | Traditional Chinese medicinal preparation for treating aplastic anemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102772685A true CN102772685A (en) | 2012-11-14 |
| CN102772685B CN102772685B (en) | 2014-07-02 |
Family
ID=47117941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210243793.0A Expired - Fee Related CN102772685B (en) | 2012-07-16 | 2012-07-16 | Traditional Chinese medicinal preparation for treating aplastic anemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102772685B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1390588A (en) * | 2002-08-06 | 2003-01-15 | 王凯 | Composite medicine for treating leukemia |
| CN1879841A (en) * | 2006-05-17 | 2006-12-20 | 郭富红 | A Chinese medicine for treating leukemia |
| CN102512592A (en) * | 2011-12-16 | 2012-06-27 | 河南科技大学第一附属医院 | Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same |
-
2012
- 2012-07-16 CN CN201210243793.0A patent/CN102772685B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1390588A (en) * | 2002-08-06 | 2003-01-15 | 王凯 | Composite medicine for treating leukemia |
| CN1879841A (en) * | 2006-05-17 | 2006-12-20 | 郭富红 | A Chinese medicine for treating leukemia |
| CN102512592A (en) * | 2011-12-16 | 2012-06-27 | 河南科技大学第一附属医院 | Traditional Chinese medicine capsule for treating refractory idiopathic thrombocytopenic purpura and preparation method for same |
Non-Patent Citations (2)
| Title |
|---|
| 李文涛等: "基于中医治疗血液病方剂的数据挖掘", 《2011年中国药学大会暨第11届中国药师周论文集》 * |
| 王爱萍等: "药物治疗过敏性紫癜的研究进展", 《中国药业》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102772685B (en) | 2014-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101366892A (en) | Chinese medicinal composition for treating menorrhalgia | |
| CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
| CN103705878B (en) | One treats migraine Chinese medicine preparation | |
| CN102961707A (en) | Traditional Chinese medicine for treating chronic renal failure | |
| CN102886033B (en) | Traditional Chinese medicine preparation for promoting postpartum recovery of parturients and shortening lochial time | |
| CN103784602A (en) | Traditional Chinese medicine for treating iron-deficiency anemia | |
| CN102772685B (en) | Traditional Chinese medicinal preparation for treating aplastic anemia | |
| CN104027775A (en) | Traditional Chinese medicine for treating thromboangiitis obliterans | |
| CN104435545B (en) | A kind of Chinese medicine preparation for treating caused by benzene leukopenia | |
| CN105343518A (en) | Traditional Chinese medicine formula for treating chronic aplastic anemia and preparation method thereof | |
| CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
| CN101856423A (en) | Medicament for treating menoxenia and preparation method thereof | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN102727765A (en) | Internally-used medicine for treating aplastic anemia by nourishing yin and yang | |
| CN102727710B (en) | Medicine for treating aplastic anemia | |
| CN102309648A (en) | Traditional Chinese medicine prescription for treating postpartum retention of lochia | |
| CN103845555A (en) | Traditional Chinese medicine for treating lumbocrural pain | |
| CN102908598B (en) | Medicine for treating children fungal pneumonia | |
| CN103751607A (en) | Traditional Chinese medicine composition for the treatment of aplastic anemia | |
| CN103830308A (en) | Traditional Chinese medicine for treating postnatal milk lack | |
| CN102727747B (en) | Medicine for treating aplastic anemia through detoxification | |
| CN103599482B (en) | A kind of Chinese medicine for the treatment of lochiorrhea | |
| CN102836404B (en) | Chinese medicine for treating chronic nephritis by using ludwigia octovalvis | |
| CN103285289A (en) | Traditional Chinese medicine for treating arthralgia | |
| CN102274373A (en) | Traditional Chinese medicine for treating hypomenorrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140702 Termination date: 20150716 |
|
| EXPY | Termination of patent right or utility model |